Cutaneous or Subcutaneous Lymph Node
1 clinical trials · Condition
◉ Watch Cutaneous or Subcutaneous Lymph Node
| Record | Firm | Date |
|---|---|---|
| Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611 (NCT02509507) | Amgen | 2016-02-05 |
Track Cutaneous or Subcutaneous Lymph Node automatically
Every clearance here is in the API, with alerts when new ones post.